Castor And Fischer Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 17-07-2024
- Revenue 2.03%
(FY 2023)
- Profit 1.05%
(FY 2023)
- Ebitda 34.16%
(FY 2023)
- Net Worth 12.61%
(FY 2023)
- Total Assets 8.17%
(FY 2023)
About Castor And Fischer Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M.
Nithi Mark and Maria Goretti serve as directors at the Company.
- CIN/LLPIN
U51397KL2009PTC024701
- Company No.
024701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Chalakudy, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Castor And Fischer Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nithi Mark  | Managing Director | 12-Mar-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maria Goretti | Director | 12-Mar-2015 | Current |
Financial Performance and Corporate Structure Insights of Castor And Fischer Pharma.
Castor And Fischer Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.03% increase. The company also saw a slight improvement in profitability, with a 1.05% increase in profit. The company's net worth Soared by an impressive increase of 12.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Castor And Fischer Pharma?
In 2023, Castor And Fischer Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 19 Nov 2013 | ₹3.00 M | Open |
How Many Employees Work at Castor And Fischer Pharma?
Unlock and access historical data on people associated with Castor And Fischer Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Castor And Fischer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Castor And Fischer Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
